NCT06916767
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06916767
Title Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma. Substudy B: CLL Patients
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Paolo Caimi, MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.